Systematic Review
Accepted on 25 Nov 2025
Efficacy of TACE plus tyrosine kinase inhibitors and immune checkpoint inhibitors in the treatment of patients with unresectable hepatocellular carcinoma: A systematic review and Meta-analysis
in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers